NRSNW · NeuroSense Therapeutics Ltd. · Documents
Market Cap
$4.50M
Shares
1.90M
Volume · Oct 28
255
Avg daily vol (26 sessions)
4988
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 6-K | NeuroSense Therapeutics Ltd. signed an advisor collaboration to supply PrimeC through a licensed clinical treatment center, targeting first revenues in the first half of 2027, subject to legal, regulatory and operational requirements. | 2026-10-26 | — | |
| 6-K | NeuroSense Therapeutics filed a U.S. patent application covering PrimeC's use for traumatic brain injury, including concussion, blast-related injury and CTE. If granted, the patent is expected to provide protection through 2047. | 2026-10-19 | — | |
| 6-K | NeuroSense scheduled a Nasdaq hearing for November 10, 2026 after appealing the October 1, 2026 delisting determination; the appeal keeps shares trading while it seeks an exception of up to 180 days. | 2026-10-13 | — | |
| 6-K | NeuroSense Therapeutics Ltd. regained Nasdaq minimum bid price compliance and plans to appeal $35 million minimum market value delisting determination. It seeks up to 180 days, and its bids were $1.00 per share or greater for 10 consecutive business days. | 2026-10-02 | — | |
| 6-K | NeuroSense reports PARADIGM long-term follow-up showed a statistically significant 65% reduction in death risk and median survival of 36.3 months versus 21.4 months; it targets a December 2026 Canadian NDS for PrimeC while pursuing financing and strategic alternatives. | 2026-09-25 | 2026-06-30 | |
| 6-K | — | 2026-09-09 | — | |
| 6-K | — | 2026-08-27 | — | |
| 6-K | — | 2026-08-13 | — | |
| 6-K | — | 2026-08-06 | — | |
| 6-K | — | 2026-07-31 | — | |
| 6-K | — | 2026-07-31 | — | |
| F-3/A | — | 2026-07-30 | — | |
| 6-K | — | 2026-07-22 | — | |
| 6-K | — | 2026-06-29 | — | |
| 6-K | — | 2026-06-25 | — | |
| 6-K | — | 2026-06-11 | — | |
| 6-K | — | 2026-06-09 | — | |
| 6-K | — | 2026-06-08 | — | |
| 6-K | — | 2026-04-28 | — | |
| 6-K | — | 2026-04-24 | — | |
| 6-K | — | 2026-04-06 | — | |
| 6-K | — | 2026-04-03 | — | |
| 6-K | — | 2026-03-31 | — | |
| 20-F | — | 2026-03-31 | 2025-12-31 | |
| 6-K | — | 2026-03-24 | — | |
| 6-K | — | 2026-03-16 | — | |
| 6-K | — | 2026-03-11 | — | |
| 6-K | — | 2026-02-18 | — | |
| 6-K | — | 2026-02-13 | — | |
| 6-K | — | 2026-02-09 | — | |
| F-3 | — | 2026-01-29 | — | |
| 6-K | — | 2026-01-06 | — | |
| 6-K | — | 2025-12-22 | — | |
| 6-K | — | 2025-12-08 | — | |
| 6-K | — | 2025-12-04 | — | |
| 6-K | — | 2025-11-24 | — | |
| 6-K | — | 2025-11-21 | — | |
| F-3 | — | 2025-10-28 | — | |
| 6-K | — | 2025-10-06 | — | |
| 6-K | — | 2025-09-25 | — | |
| 6-K | — | 2025-09-10 | — | |
| 6-K | — | 2025-09-04 | — | |
| 6-K | — | 2025-09-04 | — | |
| 6-K | — | 2025-09-02 | — | |
| 6-K | — | 2025-08-21 | — | |
| 6-K | — | 2025-08-20 | — | |
| 6-K | — | 2025-08-01 | 2025-06-30 | |
| 6-K | — | 2025-07-10 | — | |
| 6-K | — | 2025-06-26 | — | |
| 6-K | — | 2025-05-07 | — |
Showing 1–50 of 195 filings